Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
暂无分享,去创建一个
C. Bucana | F. Khuri | W. Hong | J. Lee | R. Herbst | I. Fidler | H. Kuniyasu | S. Yano | D. Liu | F. Guo | B. Kemp | Diane Liu | Hiroki Kuniyasu | Seiji Yano | J. Lee | W. Hong | Isaiah J. Fidler | Roy S. Herbst | Bonnie L. Kemp | Fang Guo | W. K. Hong
[1] N. Weidner,et al. Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up , 1999 .
[2] C. Angeletti,et al. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas , 1999, British Journal of Cancer.
[3] N. Weidner,et al. Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up. , 1999, Clinical lung cancer.
[4] I. Fidler,et al. Critical determinants of cancer metastasis: rationale for therapy , 1999, Cancer Chemotherapy and Pharmacology.
[5] L. Ellis,et al. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] W. Richards,et al. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Yasumoto,et al. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. , 1998, The Journal of thoracic and cardiovascular surgery.
[8] L. Ellis,et al. Molecular determinants of angiogenesis in cancer metastasis. , 1998, The cancer journal from Scientific American.
[9] R. Muraoka,et al. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. , 1998, The Annals of thoracic surgery.
[10] R. Shivers,et al. Quantitative comparison of the morphology of the microvasculature of primary lung lesions and metastatic brain tumours. , 1998, Journal of submicroscopic cytology and pathology.
[11] C. Bucana,et al. Expression of metastasis-related genes in surgical specimens of human gastric cancer can predict disease recurrence. , 1998, European journal of cancer.
[12] I. Fidler,et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. , 1998, The American journal of pathology.
[13] M. Buyse,et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] I. Takanami,et al. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. , 1997, Anticancer research.
[15] C. Angeletti,et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. , 1997, Journal of the National Cancer Institute.
[16] C. Bucana,et al. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.
[17] L. Ellis,et al. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. , 1996, The American journal of pathology.
[18] I. Fidler,et al. Regulation of tumor angiogenesis by organ-specific cytokines. , 1996, Current topics in microbiology and immunology.
[19] L. Ellis,et al. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] D. Harpole,et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence , 1995, Cancer.
[21] A. Harris,et al. Microvessel count predicts metastatic disease and survival in non‐small cell lung cancer , 1995, The Journal of pathology.
[22] L. Ellis,et al. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. , 1995, The American journal of pathology.
[23] C. Bucana,et al. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. , 1994, The American journal of pathology.
[24] C. Bucana,et al. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.
[25] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[26] A. Harris,et al. bcl-2 protein in non-small-cell lung carcinoma. , 1993, The New England journal of medicine.
[27] C. Bucana,et al. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] M. Takeichi,et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.
[29] L. Ellis,et al. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. , 1993, Cancer research.
[30] C. Bucana,et al. Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice. , 1992, The American journal of pathology.
[31] D. Brigati,et al. Automated Molecular Pathology : One Hour In Situ DNA Hybridization , 1991 .
[32] W. Birchmeier,et al. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. , 1991, Cancer research.
[33] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[34] J. Fiddes,et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.
[35] A. Sahin,et al. Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. , 1991, The New England journal of medicine.
[36] Y Shimoyama,et al. Expression of E- and P-cadherin in gastric carcinomas. , 1991, Cancer research.
[37] M. Takeichi,et al. Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.
[38] G. Nicolson,et al. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. , 1991, Cancer research.
[39] I. Fidler,et al. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.
[40] S. Rodenhuis,et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.
[41] L. Matrisian,et al. Stromelysin/transin and tumor progression. , 1990, Seminars in cancer biology.
[42] L. Liotta,et al. Metalloproteinases and cancer invasion. , 1990, Seminars in cancer biology.
[43] M. Teramachi,et al. [Results of surgery in non-small cell lung cancer]. , 1990, Bulletin of the Chest Disease Research Institute, Kyoto University.
[44] I. Fidler,et al. Genetic control of cancer metastasis. , 1990, Journal of the National Cancer Institute.
[45] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[46] S. Hirohashi,et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.
[47] R. Tsuchiya,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.
[48] E. Appella,et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[49] J. Seltzer,et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.
[50] M. Takeichi,et al. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. , 1988, Development.
[51] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Weinberg,et al. Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.
[53] M. Caruthers,et al. Chemical synthesis and biological studies on mutated gene-control regions. , 1983, Cold Spring Harbor Symposia on Quantitative Biology.
[54] W F Taylor,et al. Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.
[55] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[56] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.